Pantoprazole antacid Sandoz Filmtabl 20 mg 7 pcs

What is Pantoprazole antacid Sandoz and when is it used?

The active ingredient in Pantoprazole antacid Sandoz, pantoprazole, belongs to the class of proton pump inhibitors. It blocks the enzyme responsible for releasing acid in the stomach (the proton pump).

Pantoprazole Sandoz is used in adults for the short-term treatment of the symptoms of burning and acid reflux caused by stomach acid flowing back up the esophagus.

When should Pantoprazole Sandoz not be taken?

Do not use Pantoprazole Sandoz with known hypersensitivity to the active ingredient pantoprazole, other proton pump inhibitors or one of the excipients of Pantoprazole antacid Sandoz.

Pantoprazole antacid Sandoz must not be taken by children and adolescents. Pantoprazole antacid Sandoz should only be taken during pregnancy and breastfeeding after consulting a doctor.

When is caution required when taking Pantoprazole antacid Sandoz?

Please inform your doctor immediately in the following situations:

• unintentional, unexplainable weight loss,
• inexplicable pale appearance and feeling of weakness (An aemia),
• if you have blood in your stools or if your stools are black in colour,
• difficulty swallowing,
• repeated vomiting,
• vomiting blood,
• stomach pain,
• severe and/or persistent diarrhoea,
• the appearance of a skin rash, especially in sun-exposed areas of the skin, as you may need to stop treatment with Pantoprazole antacid Sandoz. Don't forget to mention other symptoms, such as joint pain.

Please talk to your doctor before taking Pantoprazole Sandoz if you have:

• if you have already had a stomach ulcer or an operation on your gastrointestinal tract,
• if you have been taking a medicine for indigestion or acid reflux for 4 weeks or more continuously,
• if you have jaundice or liver problems,
• if you have any other co-existing serious illness,
• if you are about to have an endoscopic examination (e.g. gastroscopy or breath test),
• you are older than 55 years and treat digestive disorders with non-prescription medicines on a daily basis,
• you are older than 55 years of age and have new or recently changed symptoms,
• if you have ever had a treatment with pantoprazole anta cid Sandoz, which also reduces stomach acid, have experienced skin reactions.

Pantoprazole antacid Sandoz can affect the effectiveness of other medicines. Therefore, tell your doctor, pharmacist or druggist if you are taking other medicines, such as:

• medicines for fungal infections,
• erlotinib for the treatment of certain types of cancer,
• methotrexate for cancer,
• medicines to thin the blood or medicines for HIV infections (e.g Atazanavir, ritonavir).

Concomitant use of these medicines should be avoided.

Do not take Pantoprazole Sandoz with other medicines that reduce the amount of acid in the stomach, such as another proton pump inhibitor (omeprazole, lansoprazole or rabeprazole) or an H2 antagonist (e.g. ranitidine).

However, if necessary, you may use Pantoprazole antacid Sandoz together with antacids (e.g. Magaldrat, Algic acid, sodium bicarbonate, aluminum hydroxide, magnesium carbonate or combinations thereof).

If you experience side effects such as dizziness or blurred vision, you should not drive or use machines.

If you take Pantoprazole antacid Sandoz for more than 3 months, it is possible that the levels of magnesium in your blood may fall. Low magnesium levels are manifested by fatigue, involuntary muscle tension, confusion, cramps, dizziness and increased heart rate. If you experience any of these side effects, please tell your doctor immediately. Low magnesium levels can also lead to a decrease in blood potassium and calcium levels. Your doctor may do regular blood tests to monitor your magnesium levels.

Taking proton pump inhibitors such as Pantoprazole Sandoz, especially for more than a year, may slightly increase your risk of fractures in your hip, wrist or spine. Tell your doctor if you have osteoporosis or are taking corticosteroids (these medicines can increase the risk of osteoporosis).

Tell your doctor, pharmacist or druggist if you are going to have specific blood tests (chromogranin A) before starting treatment.

This medicine contains less than 1 mmol sodium (23 mg) per tablet, i.e. i.e. it is almost «sodium-free».

This medicine contains the dye cochineal red A (E124) and can cause allergic reactions.

Inform your doctor, pharmacist or druggist if you

• suffer from other diseases,
• have allergies or
• other medicines (including those you bought yourself!) ingested or applied externally.

Can Pantoprazole antacid Sandoz be taken while pregnant or breastfeeding?

If you are pregnant or planning to become pregnant, or if you are breastfeeding, you must not take Pantoprazole antacid Sandoz without consulting your doctor.

How do you use Pantoprazole antacid Sandoz?

Take Pantoprazole antacid Sandoz always as described here. Ask your doctor, pharmacist or druggist if you are not sure.

The adult dose is one enteric-coated film-coated tablet per day.

It is possible that the film-coated tablets must be taken for 2-3 consecutive days in order to improve symptoms. Stop taking the tablets when you are completely symptom-free.

If there is no improvement in symptoms within 2 weeks of continuous treatment, you should consult your doctor.

The treatment should not last longer than 4 weeks without a doctor's consultation.

Pantoprazole antacid Sandoz gastro-resistant film-coated tablets are whole 1 hour before a meal with a little water increase.

If you have taken more than the recommended dose of 1 film-coated tablet per day, tell your doctor, pharmacist or druggist. There are no known symptoms of overdose.

If you forget to take a tablet, do not double the dose. Instead, take the next dose at the usual time.

Stick to the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist bbetween your doctor, pharmacist or druggist.

What side effects can Pantoprazole antacid Sandoz have?

Common (affects 1 to 10 users in 100)

Benign growths of the gastric mucosa.

Uncommon (affects 1 to 10 users in 1000)

Sleep disorders, headache , dizziness, diarrhea, nausea and vomiting, flatulence and bloating, constipation, dry mouth, abdominal pain and discomfort, skin rashes, reddening of the skin, itching, weakness, tiredness or general malaise.

Rare (affects 1 to 10 in 10,000 users)

Immediate-type hypersensitivity reactions (dizziness, increased heart rate, sweating), weight changes , depressive moods and aggravation of pre-existing depression, taste disorders, visual disturbances and blurred vision, hives (severe itchy skin rash, hives), joint and muscle pain, enlargement of the male breasts, increased body temperature and swelling of the arms and legs due to fluid retention (oedema).

Very rare (affects less than 1 in 10,000 users)

Disorientation and deterioration in before Existing disorientation, especially in people who are predisposed accordingly.

Individual cases

Delusions and confusion in predisposed people. If these symptoms already exist, they can be made worse by Pantoprazole antacid Sandoz. Decreased levels of certain minerals in the blood, rash, which may be associated with pain in the joints.

Inflammation of the large bowel causing persistent watery diarrhoea.

Side effects seen in blood tests include:

• Raised liver function tests have been reported uncommonly.
• Rarely, increases in bilirubin and blood fat levels have occurred.
• Decrease in blood platelets have been reported very rarely, which can lead to bleeding or bruising, and a reduction in the number of white blood cells, which can cause more infections.

Stop taking Pantoprazole Sandoz and see your doctor straight away if you experience any of the following side effects:

• Severe allergic reactions: swelling of the tongue or throat, difficulty swallowing, hives, difficulty breathing, allergic swelling of the face and throat (Quincke's edema, angioedema), severe drowsiness with a racing heart and heavy sweating.
• Serious skin changes such as blistering and rapid deterioration of your general condition, skin damage (including minor bleeding) of the eyes, nose, mouth and lips or genitals (Stevens-Johnson syndrome, Lyell's syndrome, erythema multiforme) and sensitivity to light.
• Other serious conditions : Yellowing of the skin or eyes (severe damage to liver cells, jaundice), fever, skin rash and enlarged kidneys, sometimes accompanied by painful urination and pain in the lower back (severe inflammation of the kidneys).

If you get any side effects, talk to your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet.

What else should you be aware of?

The medicine may only be used up to the date marked «EXP» on the package.

Storage instructions

Store in the original packaging at room temperature (15–25°C) and out of the reach of children.

Your doctor, pharmacist or druggist can provide you with further information doctor, pharmacist or druggist. These people veradd the detailed product information.

What does Pantoprazole antacid Sandoz contain?

Active substances

1 gastro-resistant film-coated tablet of Pantoprazole antacid Sandoz contains 20 mg pantoprazole as pantoprazole sodium sesquihydrate.

Excipients

Core:

Sodium carbonate, microcrystalline cellulose, crosp ovidon, hydroxypropyl cellulose, highly disperse silicon dioxide, calcium stearate.

Intermediate coating:

Hypromellose, titanium dioxide, macrogol 400, quinoline yellow (E104), iron oxide yellow, cochineal red A (E124).

Enteric coating:

Methacrylic acid-ethyl acrylate copolymer (1:1), dispersion polysorbate 80, sodium dodecyl sulphate), triethyl citrate. Yellow iron oxide (E 172)

Authorization number

61372 (Swissmedic)

Where can you get Pantoprazole antacid Sandoz? Which packs are available?

In pharmacies and drugstores, without a doctor's prescription.

Packs with 7 and 14 gastro-resistant film-coated tablets.

Authorization holder

Sandoz Pharmaceuticals AG, Risch; Domicile: Rotkreuz

This leaflet was last checked by the drug authority (Swissmedic) in January 2020.